Field evaluation of the CRT and ACON chlamydia point-of-care tests in a tropical, low-resource setting

Sexually Transmitted Infections

Volumn 90, Issue 3, 2014, Pages 179-184

  Hurly, Dermot S ^a   Buhrer Skinner, M ^a   Badman, S G ^b   Bulu, S ^c   Tabrizi, S N ^d,e,f   Tarivonda, L ^g   Muller, R ^a,h  

^a JAMES COOK UNIVERSITY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c KPH Clinic   (Vanuatu)

^d ROYAL WOMEN'S HOSPITAL   (Australia)

^e MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g Vanuatu Ministry of Health   (Vanuatu)

^h Tropical Health Solutions Pty Ltd   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BACTERIAL LOAD; CHLAMYDIA; CHLAMYDIA RAPID TEST; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID AMPLIFICATION; POINT OF CARE TESTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; URINALYSIS;

CHLAMYDIA INFECTION; CHLAMYDIA TRACHOMATIS; DEVELOPING WORLD; LABORATORY METHODS; TESTING;

ADULT; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MALE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POINT-OF-CARE SYSTEMS; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; REAGENT STRIPS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; VAGINAL SMEARS; VANUATU;

EID: 84899524655     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2013-051246     Document Type: Article

References (30)

1. WHO. Global incidence and prevalence of selected curable sexually transmitted infections - 2008, 2012. http://apps.who.int/iris/bitstream/10665/ 75181/1/9789241503839-eng.pdf. (accessed 4 Jun 2013).
2. Meyers DS, Halvorson H, Luckhaupt S. Screening for chlamydial infection: an evidence update for the U.S. Preventive Services Task Force. Ann Intern Med 2007;147:135-42. (Pubitemid 351664618)
3. Sexton J, Garnett G, Rottingen JA. Metaanalysis and metaregression in interpreting study variability in the impact of sexually transmitted diseases on susceptibility to HIV infection. Sex Transm Dis 2005;32:351-7. (Pubitemid 40727179)
4. Hayes R, Watson-Jones D, Celum C, et al. Treatment of sexually transmitted infections for HIV prevention: end of the road or new beginning? Aids 2010;24(Suppl 4):S15-26.
5. Vanuatu Census 2009. In: Office VNS, 2009. http://www.vnso.gov.vu/index. php?Itemid=18 (accessed 25 Feb 2012).
6. Breaking the Silence. Responding to the STI epidemic in the Pacific, STI Regional Working Group.: Secretariat of the Pacific Community, 2010. http://www.spc.int/hiv/index2.php?option=com-docman&task=doc-view&gid= 423&Itemid=148 (accessed 14 Feb 13).
7. Cliffe SJ, Tabrizi S, Sullivan EA. Chlamydia in the Pacific region, the silent epidemic. Sex Transm Dis 2008;35:801-6.
8. Sullivan EA, Abel M, Tabrizi S, et al. Prevalence of sexually transmitted infections among antenatal women in Vanuatu, 1999-2000. Sex Transm Dis 2003;30:362-6. (Pubitemid 36397841)
9. Second Generation Surveillance Surveys of HIV, other STIs and Risk Behaviours in 6 Pacific Island Countries (2004-2005). World Health Organization Western Pacific Regional Office, the Secretariat of the Pacific Community, The University of New South Wales. http://www.wpro.who.int/hiv/documents/docs/ SGSFINALDOCUMENT.pdf (accessed 14 Feb 2013).
10. Herring A, Ballard R, Mabey D, et al. Initiative WTSTDD. Evaluation of rapid diagnostic tests: chlamydia and gonorrhoea. Nature reviews. Microbiology 2006;4(12 Suppl):S41-8. (Pubitemid 44773209)
11. Pettifor A, Walsh J, Wilkins V, et al. How effective is syndromic management of STDs?: a review of current studies. Sex Transm Dis 2000;27:371-85. (Pubitemid 30618554)
12. Vickerman P, Watts C, Alary M, et al. Sensitivity requirements for the point of care diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in women. Sex Transm Infect 2003;79:363-7.
13. Low N, Broutet N, Adu-Sarkodie Y, et al. Global control of sexually transmitted infections. Lancet 2006;368:2001-16. (Pubitemid 44822624)
14. Tucker JD, Bien CH, Peeling RW. Point-of-care testing for sexually transmitted infections: recent advances and implications for disease control. Curr Opin Infect Dis 2013;26:73-9.
15. Trollope-Kumar K, Guyatt G. Syndromic approach for treatment of STIs: time for a change. Lancet 2006;367:1380-1.
16. Peeling RW, Holmes KK, Mabey D, et al. Rapid tests for sexually transmitted infections (STIs): the way forward. Sex Transm Infect 2006;82(Suppl 5):v1-6. (Pubitemid 46293817)
17. Wisniewski CA, White JA, Michel CE, et al. Optimal method of collection of first-void urine for diagnosis of Chlamydia trachomatis infection in men. J Clin Microbiol 2008;46:1466-9. (Pubitemid 351563592)
18. Stevens MP, Twin J, Fairley CK, et al. Development and evaluation of an ompA quantitative real-time PCR assay for Chlamydia trachomatis serovar determination. J Clin Microbiol 2010;48:2060-5.
19. Nadala EC, Goh BT, Magbanua JP, et al. Performance evaluation of a new rapid urine test for chlamydia in men: prospective cohort study. BMJ 2009;339:b2655.
20. Saison F, Mahilum-Tapay L, Michel CE, et al. Prevalence of Chlamydia trachomatis infection among low- and high-risk Filipino women and performance of Chlamydia rapid tests in resource-limited settings. J Clin Microbiol 2007;45:4011-7. (Pubitemid 350274885)
21. Mahilum-Tapay L, Laitila V, Wawrzyniak JJ, et al. New point of care Chlamydia Rapid Test-bridging the gap between diagnosis and treatment: performance evaluation study. BMJ 2007;335:1190-4. (Pubitemid 350273302)
22. Hislop J, Quayyum Z, Flett G, et al. Systematic review of the clinical effectiveness and cost-effectiveness of rapid point-of-care tests for the detection of genital chlamydia infection in women and men. Health Technol Assess 2010;14:1-97, iii-iv.
23. van der Helm JJ, Sabajo LO, Grunberg AW, et al. Point-of-care test for detection of urogenital chlamydia in women shows low sensitivity. A performance evaluation study in two clinics in Suriname. PLoS ONE 2012;7:e32122.
24. Walker J, Tabrizi SN, Fairley CK, et al. Chlamydia trachomatis incidence and re-infection among young women-behavioural and microbiological characteristics. PLoS ONE 2012;7:e37778.
25. Wiggins R, Graf S, Low N, et al. Real-time quantitative PCR to determine chlamydial load in men and women in a community setting. J Clin Microbiol 2009;47:1824-9.
26. Michel CE, Roper KG, Divena MA, et al. Correlation of clinical trachoma and infection in Aboriginal communities. PLoS Neglected Trop Diseases 2011;5:e986.
27. Michel CE, Solomon AW, Magbanua JP, et al. Field evaluation of a rapid point-of-care assay for targeting antibiotic treatment for trachoma control: a comparative study. Lancet 2006;367:1585-90.
28. Harding-Esch EM, Holland MJ, Schemann JF, et al. Diagnostic accuracy of a prototype point-of-care test for ocular Chlamydia trachomatis under field conditions in The Gambia and Senegal. PLoS Neglected Trop Dis 2011;5:e1234.
29. Michel CE, Sonnex C, Carne CA, et al. Chlamydia trachomatis load at matched anatomic sites: implications for screening strategies. J Clin Microbiol 2007;45:1395-402. (Pubitemid 46762389)
30. Mathew T, O'Mahony C, Mallinson H. Shortening the voiding interval for men having chlamydia nucleic acid amplification tests. Int J STD AIDS 2009;20:752-3.